LENSAR Inc
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $100.6M
- Price
- $8.68
- % Change (Daily % change from the live per-ticker quote feed.)
- +2.84%
- Volume
- 167.3K
About
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Quick stats
Shares outstanding12.3M
Computed float7.7M
Float / shares62.3%
Cash runway (months)30.5
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001320350
Websitehttps://www.lensar.com
AI Summary
AI-generated1/8
majorbullishearnings
LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
LENSAR reported Q2 revenue of $16.5 million, up 18% year-over-year, driven by a 20% increase in recurring revenue to $13.7 million and strong demand for the ALLY System.
The company achieved profitability with net income of $3.5 million and Adjusted EBITDA of $3.6 million, compared to losses in the prior-year period, aided by lower operating expenses and a $1.1 million tariff refund.
Operational momentum continued with 10 new ALLY System placements, growing the installed base to 215 units, while maintaining a backlog of 13 systems pending installation.
Red flags
- Cash position decreased from $18.0 million to $13.6 million over the past six months despite reporting positive net income.
- Net income was positively impacted by a non-recurring $1.1 million tariff refund and changes in fair value of warrant liabilities.